Article Information
PubMed
Published By
History
- Received November 18, 2011
- Revision received March 12, 2012
- Accepted March 15, 2012
- First published May 2, 2012.
- Version of record published May 2, 2012.
Copyright & Usage
Copyright © 2012 the authors 0270-6474/12/326197-12$15.00/0
Author Information
Author contributions
Author contributions: K.B.H., K.K.O., and S.F.T. designed research; K.B.H. and K.K.O. performed research; K.B.H. and K.K.O. analyzed data; K.B.H., K.K.O., and S.F.T. wrote the paper.
↵*K.B.H. and K.K.O. contributed equally to this work.
Disclosures
- Received November 18, 2011.
- Revision received March 12, 2012.
- Accepted March 15, 2012.
This work was supported by National Institutes of Health–National Institute of Neurological Disorders and Stroke Grants NS036654 and NS065371 (S.F.T.), National Institute on Drug Abuse Grant DA015040 (K.K.O.), and National Institute of General Medical Sciences Grant GM008602 (K.K.O.). We thank David J. A. Wyllie for comments on this manuscript. We also thank Tim M. Acker for assistance in the determination of compound solubility.
The authors declare no competing financial interests.
- Correspondence should be addressed to Stephen F. Traynelis, Department of Pharmacology, Emory University School of Medicine, 1510 Clifton Road, Rollins Research Center, Atlanta, GA 30322. strayne{at}emory.edu
Online Impact